Dimerix LimitedASX: DXB

New Data Supports Biological Rationale for DMX-200 in FSGS

· Issued by Dimerix Limited via ASX

Filed with ASX · · 17 pages · English

Release

For Immediate Release NEW HUMAN DATA STRENGTHENS BIOLOGICAL RATIONALE FOR DMX-200 IN FSGS Highlights • New data presented at Kidney Week 2026 provides additional biological evidence supporting the 1 2 inflammatory mechanism of action of DMX-200 which targets CCR2 in FSGS • Independent...

Dimerix Limited on 6ix

Earlier from Dimerix

Later from Dimerix

All Dimerix news releases